ArticlePloS one2022
Reduced palmitic acid content in soybean as a result of mutation in FATB1a.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fatty acid component of commodity soybean seeds typically consists of approximately 12-15% saturated fatty acids in the form of palmitic acid and stearic acid. An important goal in soybean breeding is the reduction of saturated fats, in order to produce healthier vegetable oils for food applications. Genetic approaches have been instrumental in reducing levels of palmitic acid, which is the most abundant saturated fat in soybean seeds. In this study we describe a new mutant allele of the FATB1a gene that encodes a palmitoyl-acyl carrier protein thioesterase. The mutation is expected to result in early termination of the FATB1A protein and mutant seeds carrying this allele contain 5.5% palmitic acid. This new allele can be introduced into conventional soybean lines, alone or in combination with other modifications to generate soybean lines with improved oil composition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.